StonvexLoading…
StonvexStonvexStonvexCore line items from ABT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $44.33B | $41.95B | $40.11B | $43.65B |
Operating Income | $8.05B | $6.83B | $6.48B | $8.36B |
Net Income | $6.52B | $13.40B | $5.72B | $6.93B |
EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 |
Total Assets | $86.71B | $81.41B | $73.21B | $74.44B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.52B | $7.62B | $6.90B | $9.88B |
Free Cash Flow OCF − CapEx | $7.39B | $6.35B | $5.06B | $7.80B |
Shares Outstanding | 1.75B | 1.75B | 1.75B | 1.76B |